Medical Condition News

RSS

Patients, scientists in different corners for cancer drug fight

The drug, Avastin, will be the subject of an unusual Food and Drug Administration hearing to revisit a panel vote last July that steered many doctors away from prescribing the drug for the treatment of breast cancer.

29 Jun 2011

Cayenne Medical introduces second generation device for treatment of traumatic meniscal tears

Cayenne Medical, Inc., a private sports medicine device company, announces the launch of CrossFix II Meniscal Repair System, its second generation device for treatment of traumatic meniscal tears.

29 Jun 2011

LVAD therapy an 'attractive option' for heart failure patients 70 years of age or older

Results of a clinical research study at Sharp Memorial Hospital indicate that patients 70 years of age or older have good functional recovery, survival and quality of life at two years when undergoing left ventricular assist device (LVAD) therapy for heart failure.

29 Jun 2011

Zalicus commences Synavive SYNERGY Phase 2b clinical trial for rheumatoid arthritis

Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced the initiation of the SYNERGY trial, a Phase 2b clinical trial evaluating Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).

29 Jun 2011

GenSpera and University of Copenhagen collaborate on 'Sustainable Production of Thapsigargin using Light'

GenSpera, Inc. has entered into a cooperation agreement with the University of Copenhagen, in Copenhagen, Denmark, to collaborate on the "SPOTLight" (Sustainable Production of Thapsigargin using Light) project.

29 Jun 2011

Threshold commences combination Phase 1/2 trial of TH-302 and sunitinib for RCC, GIST and PNET

Threshold Pharmaceuticals, Inc., today announced the initiation of a Phase 1/2 dose escalation clinical trial of TH-302 in combination with sunitinib in patients with advanced renal cell carcinoma (RCC), gastrointestinal stromal tumor (GIST) and pancreatic neuroendocrine tumor (PNET).

29 Jun 2011

ICU nurses doubt whether clinical neurological examination can establish brain death

More than half of Sweden's intensive care nurses doubt that a clinical neurological examination can establish that a patient is brain dead. Intensive care nurses also perceive that this uncertainty can affect relatives when the question of organ donation is raised, is reveiled in a thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden.

29 Jun 2011

Suneva Medical receives Health Canada marketing approval for Bellafill

Suneva Medical, a privately-held aesthetic medical device company, today announced the expansion of its core aesthetics injectable business with approval from Health Canada to market Bellafill™, its long lasting dermal filler for nasolabial folds or smile line correction.

29 Jun 2011

Children and adolescents who eat candy less likely to be overweight or obese

Children and adolescents who eat candy tend to weigh less than their non-consuming counterparts, according to a new study published in Food & Nutrition Research, a peer-reviewed journal.

29 Jun 2011

Two-pronged 'hybrid' procedure for treatment of atrial fibrillation

Doctors at Washington University School of Medicine in St. Louis are performing a new procedure to treat atrial fibrillation, a common irregular heartbeat.

29 Jun 2011

DiagnoCure, Signal Genetics enter commercialization collaboration for Previstage GCC Colorectal Cancer Staging Test

Signal Genetics, a privately held predictive genetic testing company focusing on oncology, and DiagnoCure, Inc., a life sciences company that develops and commercializes high-value cancer diagnostic tests, today announced a collaboration arrangement valued at US$13.3M over the first five years.

29 Jun 2011

USPTO awards patent for key therapeutic ingredient in CNVN202 targeted molecular cancer therapy

Convergen LifeSciences, Inc. announced today that a United States Patent has been awarded by the U.S. Patent and Trademark Office jointly to The University of Texas System Board of Regents and The Secretary, U.S. Department of Health and Human Services.

29 Jun 2011

Mount Sinai gene therapy improves cardiac function in people with severe heart failure

Researchers at Mount Sinai School of Medicine have found in a Phase II trial that a gene therapy developed at Mount Sinai stabilized or improved cardiac function in people with severe heart failure. Patients receiving a high dose of the therapy, called SERCA2a, experienced substantial clinical benefit and significantly reduced cardiovascular hospitalizations, addressing a critical unmet need in this population.

29 Jun 2011

Gene PNPLA3 offers potential therapeutic target in chronic hepatitis C liver damage

New research confirms that a variant on the patatin-like phospholipase-3 (PNPLA3) gene increases risk of steatosis and fibrosis progression in patients with chronic hepatitis C virus (HCV). The PNPLA3 single nucleotide polymorphism (SNP) rs 738409 may represent an important genetic predictor and potential therapeutic target in chronic HCV liver damage.

29 Jun 2011

Emotional empathy linked to physiological responses to angry faces

Egocentric, self-centred, and insensitive to the needs of others: these social problems often arise in people with severe traumatic brain injury (TBI) and have been attributed in part to a loss of emotional empathy, the capacity to recognise and understand the emotions of other people.

29 Jun 2011

Medical Condition News

Patients, scientists in different corners for cancer drug fight

Cayenne Medical introduces second generation device for treatment of traumatic meniscal tears

LVAD therapy an 'attractive option' for heart failure patients 70 years of age or older

Zalicus commences Synavive SYNERGY Phase 2b clinical trial for rheumatoid arthritis

GenSpera and University of Copenhagen collaborate on 'Sustainable Production of Thapsigargin using Light'

Threshold commences combination Phase 1/2 trial of TH-302 and sunitinib for RCC, GIST and PNET

ICU nurses doubt whether clinical neurological examination can establish brain death

Suneva Medical receives Health Canada marketing approval for Bellafill

Children and adolescents who eat candy less likely to be overweight or obese

Two-pronged 'hybrid' procedure for treatment of atrial fibrillation

DiagnoCure, Signal Genetics enter commercialization collaboration for Previstage GCC Colorectal Cancer Staging Test

USPTO awards patent for key therapeutic ingredient in CNVN202 targeted molecular cancer therapy

Mount Sinai gene therapy improves cardiac function in people with severe heart failure

Gene PNPLA3 offers potential therapeutic target in chronic hepatitis C liver damage

Emotional empathy linked to physiological responses to angry faces

Some adult survivors of childhood cancer are at risk for multiple cancers

Diet sodas and artificial sweeteners may not be healthy alternatives

Fidgeting contributes to cardiorespiratory fitness

Drug-resistant scarlet fever outbreak has infected nearly 550 people in Hong Kong

Obese people already drink diet soda, so soda tax won't help

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News